PolarityTE Receives NIH Grant for a Point-of-Care Device to Treat Chronic Wounds
2020年9月21日 - 9:00PM
ビジネスワイヤ(英語)
PolarityTE, Inc. (Nasdaq: PTE) today announced it has
received notification of being awarded a Phase I Small Business
Innovation Research grant from the National Institutes of Health
(NIH) for an application titled, “Fluid Management System for Point
of Care Device for Novel Regenerative Treatment for Chronic
Wounds.” The Phase I grant, which totals approximately $245,000, is
funded over a six-month period and will support research to apply
for a subsequent larger Phase II grant.
“I’m proud of the hard work the PolarityTE team dedicated to
pursuing this grant and we are pleased to see that work validated
by an award from the NIH,” said David Seaburg, Chief Executive
Officer of PolarityTE. Mr. Seaburg continued, “We will continue to
leverage our scientific team’s talent and pursue opportunities we
believe will add value to the SkinTE™ franchise.”
“We are incredibly excited to receive this grant and look
forward to working with the NIH to generate research supporting the
development of a point-of-care device,” said Dr. Nik Sopko, MD,
PhD, Chief Scientific Officer. “We believe the ability to use
products like SkinTE in a point-of-care setting will help many more
patients gain access to novel treatments that can address unmet
needs and deliver meaningful improvements to the standard of
care.”
About PolarityTE®
PolarityTE is focused on transforming the lives of patients by
discovering, designing and developing a range of regenerative
tissue products and biomaterials for the fields of medicine,
biomedical engineering and material sciences. Rather than
manufacturing with synthetic and foreign materials within
artificially engineered environments, PolarityTE manufactures
products from the patient's own tissue and uses the patient's own
body to support the regenerative process. From a small piece of
healthy autologous tissue, the company creates an easily
deployable, dynamic and self-propagating product designed to
regenerate the target tissues. PolarityTE's innovative methods are
intended to promote and accelerate growth of the patient's tissues
to undergo a form of effective regenerative healing. Learn more at
www.PolarityTE.com – Welcome to the Shift®.
Forward Looking Statements
Certain statements contained in this release are
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. They are generally
identified by words such as "believes," "may," "expects,"
"anticipates," "intend," "plan," "will," "would," "should" and
similar expressions. Readers should not place undue reliance on
such forward-looking statements, which are based upon the Company's
beliefs and assumptions as of the date of this release. The
Company's actual results could differ materially due to the impact
of the COVID-19 pandemic and FDA regulatory matters, which cannot
be predicted, and the risk factors and other items described in
more detail in the "Risk Factors" section of the Company's Annual
Reports and other filings with the SEC (copies of which may be
obtained at www.sec.gov). Subsequent events and developments may
cause these forward-looking statements to change. The Company
specifically disclaims any obligation or intention to update or
revise these forward-looking statements as a result of changed
events or circumstances that occur after the date of this release,
except as required by applicable law. Our actual results could
differ materially due to risk factors and other items described in
more detail in the "Risk Factors" section of the Company's Annual
Reports and other filings with the SEC (copies of which may be
obtained at www.sec.gov).
POLARITYTE, the POLARITYTE logo, SKINTE, WHERE SELF REGENERATES
SELF and WELCOME TO THE SHIFT are trademarks or registered
trademarks of PolarityTE, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200921005151/en/
Investors: Rich Haerle VP, Investor Relations PolarityTE,
Inc. ir@PolarityTE.com (385) 315-0697
PolarityTE (NASDAQ:PTE)
過去 株価チャート
から 6 2024 まで 7 2024
PolarityTE (NASDAQ:PTE)
過去 株価チャート
から 7 2023 まで 7 2024